The oncogenic role of SET in HCC was first suggested by Fukukawa et al. [70] who demonstrated that SET expression is highly upregulated in progressive HCC, indicating that SET may be involved in HCC development. This evidence concerns the gene SET and hepatocellular carcinoma.